Merrimack Pharmaceuticals, Inc. MACK
15.15 0.00 (+0.00%)
May 17, 2024, 3:59 PM EDT
15.14 Day range 15.17
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -2.04M | -1.73M | -2.47M | -2.87M | -22.36M | |
| -1.18M | -1.54M | -2.46M | -3.03M | -17.33M | |
| -0.08 | -0.11 | -0.18 | -0.23 | -1.30 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 5.99M | 19.44M | 14.20M | 14.04M | 16.58M | |
| 19.19M | 19.84M | 14.75M | 16.78M | 20.08M | |
| 441.00K | 589.00K | 562.00K | 770.00K | 2.77M | |
| 18.75M | 19.25M | 14.19M | 16.01M | 17.31M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -1.52M | -1.74M | -218.00K | -4.63M | -31.37M | |
| -12.45M | 445.00K | 144.00K | 2.14M | 69.83M | |
| 521.00K | 6.53M | 239.00K | -56.00K | -42.54M | |
| -13.45M | 5.24M | 165.00K | -2.54M | -4.08M |